Sandra and Edward Meyer Cancer Center

You are here

News

We Are Weill Cornell Medicine: Dr. Olivier Elemento

Wednesday, September 21, 2016

Computational biologist Dr. Olivier Elemento was just 6 years old when he received his first microscope and computer. Now he is harnessing the power of both to spot patterns and trends in cancer that could help doctors treat the disease — and perhaps even find a cure.

"A lot of what we do involves taking patient samples and looking at what kind of mutations we see in those cancer cells," said Dr. Elemento, an associate professor of physiology and biophysics and of computational genomics in computational biomedicine, associate director of the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Al-Saud Institute for Computational Biomedicine, and head of the computational biology group at the Caryl and Israel Englander Institute for Precision Medicine. "We never forget that behind each cell, behind each number, behind each pattern, there's a patient. It reminds me that we have to work harder to make their lives better — and that's why I love what I do."

He is the latest faculty member to be featured as part of the #WeAreWCM campaign

Related Stories

Elemento Lab helps identify new class of cancer drugs

Computer to clinic: Tool developed at Weill predicts drug success

New tool predicts drug targets and IDs new anticancer compounds

Artificial Intelligence helps identify effective cancer drug combinations

Doctors using virtual reality to treat cancer patients

Englander Institute creates big data solution

Computational method uncovers new potential therapeutic option for difficult-to-treat subtype of prostate cancer

Weill Cornell team publishes details of precision medicine knowledgebase of somatic tumor mutations

Systems Biology Digs Deep, Aims High

Cancer and big data analytics

Big Data Key to Precision Medicine's Success

Changes in cancer epigenome implicated in chemotherapy resistance and lymphoma relapse

New layer of gene regulation may play key role in common lymphoma

New study describes genomic landscape of castration-resistant prostate cancer

Enzyme may hold key to B Cell lymphomas

Batting it out of the park

A new paradigm: Precision medicine

Precision medicine testing options expand with approval of EXaCT-1 test

Researchers validate precision medicine approach using new whole exome sequencing test

Precision Medicine: Working Toward Custom-Fitted Cures

The new style of tailored treatment

Gift Names Caryl and Israel Englander Institute for Precision Medicine

Fine-Combing the Cancer Transcriptome

Big Data and Bacteria: Mapping the New York Subway’s DNA

Privacy in the post-genomic era: Impossible

We Are Weill Cornell Medicine: Dr. Adrienne Phillips

We Are Weill Cornell Medicine : Dr. Silvia Formenti

We Are Weill Cornell Medicine: Dr. Christopher Barbieri

We Are Weill Cornell Medicine: Dr. Heather Yeo

We Are Weill Cornell Medicine: Sandy Allen-Bard